
    
      Safety: Treatment-Emergent AE; Treatment-Related AE, SAE and Clinical significant AE; Dose
      Limiting Toxicities (DLT). PK: Peak Plasma Concentration (Cmax), Area under the plasma
      concentration versus time curve (AUC), Time of Maximum concentration observed (Tmax).
      Efficacy: Overall Response Rate (ORR), Progression Free Survival (PFS), Overall Survival (OS)
      and Duration of Response.
    
  